Mylan Laboratories Limited

Hyderabad, India


Purpose

to co-formulate Tenofovir Disoproxil Fumarate/Emtricitabine or Emtricitabine/ Tenofovir Alafenamide with a hormone as a dual oral pill for HIV and pregnancy prevention

Division

Global Health

Date

November 2019

Region Served

GLOBAL

Committed amount

$2,558,312

Grant topic

HIV

Duration (months)

68

Grantee location

Hyderabad, India

Related work

HIV

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.